BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas

  Adaptive Biotechnologies Corporation today announced the appointment of Tycho Peterson as chief financial officer (CFO).

  March 9, 2022

   · 

  6 min read
• Pharm Country

  Cyclacel Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conference

  Cyclacel Pharmaceuticals, Inc. today announced that management will be presenting at the virtual 32nd Annual Oppenheimer Healthcare Conference and participating in the Targeted Oncology Panel as part of the Conference.

  March 9, 2022

   · 

  3 min read
• BioMidwest

  Metastatic Tumor Treatment with Novel GPX Embolic Device

  As part of an ongoing multi-center study, Fluidx Medical released additional information on treating tumors including a highly vascularized metastatic renal cell carcinoma with the GPX Embolic Device.

  March 9, 2022

   · 

  1 min read
• Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference

  Compugen Ltd. today announced that management will present at the Oppenheimer 32nd Annual Global Healthcare Conference (virtual), on Wednesday, March 16, 2022 at 11:20 am ET .

  March 9, 2022

   · 

  2 min read
• BioCapital

  REGENXBIO to Participate in Upcoming Investor Conferences in March 2022

  REGENXBIO Inc. announced it will participate in the following upcoming investor conferences.

  March 9, 2022

   · 

  1 min read
• Biotech Bay

  Bristol Myers Squibb to Participate in Upcoming Investor Conferences on March 16

  Bristol Myers Squibb announced its participation in the following investor conferences on Wednesday, March 16, 2022:

  March 9, 2022

   · 

  1 min read
• Genetown

  Save the Date: Miroculus to Host Virtual Symposium on Revolutionizing NGS Workflows on March 24, 2022

  Miroculus , Inc., a developer of revolutionary tools for personal lab automation, today announced it will host their inaugural “Science Simplified Symposium,” on Thursday, March 24, 2022, from 9:00 a.m. – 1:00 p.m. PDT.

  March 9, 2022

   · 

  1 min read
• Business

  Lipocine Announces Financial Results for the Year Ended December 31, 2021

  Lipocine Inc. today announced financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.

  March 9, 2022

   · 

  9 min read
• Mikra Cellular Sciences Receives $8.5 Million in Funding to Launch Novel Therapeutic Product

  Mikra Cellular Sciences Inc. (“Mikra”), a biosciences company driving breakthrough applications of bioactive compounds to positively impact human health and intervene before pharmaceuticals are necessary, today announced $8.5 million in funding from its parent company, Lifeist Wellness Inc.

  March 9, 2022

   · 

  3 min read
• Pharm Country

  Harmony Biosciences To Participate In Two Investor Conferences In March 2022

  Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, announced that its executive leaders will participate in the following upcoming virtual conferences.

  March 9, 2022

   · 

  1 min read